Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Activities:
Manufacturing
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
X
LinkedIn
Trending Articles
AbbVie and Gedeon Richter join forces to advance neuropsychiatric target R&D
The companies will aim to discover and progress targets for neuropsychiatric disorders
Containment in a high potent manufacturing facility
Throughout the pharmaceutical industry, there is a lack of consistency regarding the assignment of Occupational Exposure Limits (OELs) to specific bands
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Status update on ANDA for generic Advair Diskus (VR315 [US])
Vectura Group, an industry leading inhalation CDMO, confirms the announcement made by its partner Hikma Pharmaceuticals
Manufacturing
Hikma capitalises on Insys Therapeutics bankruptcy
The acquisition includes unit-dose nasal and sublingual spray manufacturing equipment as well as two pipeline products
Manufacturing
Hikma establishes distribution partnership with Melinta
The agreement covers distribution of an antibiotic effective against MRSA across the Middle East and North African region
Distribution
Hikma announces exclusive agreement with Sciecure Pharma for niche injectable antiviral medicine
Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world
Regulatory
Hikma launches Dalfampridine Extended-release tablets
Hikma Pharmaceuticals, formerly known as West-Ward Pharmaceuticals, has launched Dalfampridine Extended-release tablets, 10 mg, the generic therapeutic equivalent to Ampyra
Pharmaceutical
Hikma launches Clobazam oral suspension and Clobazam tablets
Hikma Pharmaceuticals has launched Clobazam oral suspension, 2.5 mg/mL, and Clobazam tablets, 10 and 20 mg, the generic equivalent to Onfi
Recruitment
Hikma Pharmaceuticals appoints VP of Sales and Marketing
Subscribe now